NewLink Genetics Corporation (NLNK)

[remind2]

NLNK: Developer of Ebola vax now GOVX Director.


GeoVax: GOVX @ .06, 42M float.

GeoVax has a 100% effective AIDS prevention vaccine.

GOVX brought in NLNKs Thomas Monath just as GOVX AIDS vax is starting another round of humna injection trials


Link:
https://finance.yahoo.com/news/geovax-announces-formation-scientific-advisory-140000691.html


NOTE: The person leading the development with Merck & NLNK is now a Director Of GeoVax. That is big.

"Thomas P. Monath, MD, (Chairman). Dr. Monath currently serves as Chief Scientific Officer and Chief Operating Officer of BioProtection Systems, a subsidiary of NewLink Genetics Corporation, where he is leading the development of an Ebola virus vaccine in partnership with Merck